Secondary metabolites of Curvularia sp. G6-32, an endophyte of Sapindus saponaria, with antioxidant and anticholinesterasic properties

A. D. Polli,M. Cabral,Adriana Garcia,M. Ribeiro,Benício Alves Abreu-Filho,Caroline Menicoze dos Santos,J. C. Castro,J. Pamphile,J. Azevedo,Angela Aparecida da Silva,R. C. Orlandelli,M. Sarragiotto,J. C. Polonio
DOI: https://doi.org/10.1080/14786419.2020.1739681
2020-03-16
Natural Product Research
Abstract:Abstract In the present study, the biological activity of an extract of the secondary metabolites (E-G6-32) produced by the Curvularia sp. G6-32 endophyte (isolated from the medicinal plant Sapindus saponaria L.) was investigated. The antioxidant potential was confirmed by the DPPH (22.5%) and ABTS (62.7%) assays, and the total phenolic compound content was 40 µg gallic acid equivalents/mg. The extract E-G6-32 displayed good inhibitory activity toward butyrylcholinesterase (BuChE; IC50 = 110 ± 0.05 µg mL−1). The extract E-G6-32 was subjected to spectroscopic and mass spectrometry analyses. Comparison with the literature data confirmed that (-)-asperpentyn (1) was a major component. Asperpentyn belongs to the epoxyquinone family, which has attractive structural complexity, diverse functional groups, and a broad range of biological activities, including specific enzyme inhibitory activity. Our results suggest that Curvularia sp. G6-32 is a promising source of bioactive secondary metabolites and contains (-)-asperpentyn, which has potential pharmaceutical interest.
Chemistry,Environmental Science,Medicine
What problem does this paper attempt to address?